NCT03464864View on ClinicalTrials.gov

Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 9, 2018

Primary Completion Date

June 5, 2018

Study Completion Date

June 5, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Treprostinil Inhalation Powder

Single ascending dose

Trial Locations (1)

78217

Investigational Site 441, San Antonio

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY